The Food and Drug Administration is aiming to fully approve the Pfizer-BioNTech COVID-19 vaccine by Labor Day or sooner, people familiar with the matter told The New York Times.
Because of the highly contagious Delta variant, coronavirus cases are on the rise across the United States, and the hope is that a full approval will push skeptics to get inoculated. In late 2020, the FDA granted emergency authorization to the Pfizer vaccine, and the company applied for full approval on May 7. Moderna also received emergency authorization for its vaccine, and submitted its application for final approval on June 1.
As part of the approval process, FDA employees will review hundreds of thousands of documents, looking at data on vaccine efficacy, immune responses, and breakthrough infections. Once a coronavirus vaccine is fully approved, it's expected that many schools and hospitals, as well as the city of San Francisco and the Department of Defense, will mandate that workers and students get vaccinated, the Times reports. As of Tuesday, 58 percent of Americans have received at least one dose of a COVID-19 vaccine.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
October 13 editorial cartoonsCartoons Monday's political cartoons include Donald Trump's consolation prize, government workers during shutdown, and more
-
Can Gaza momentum help end the war in Ukraine?Today's Big Question Zelenskyy’s request for long-range Tomahawk missiles hints at ‘warming relations’ between Ukraine and US
-
The Israeli hostages and Palestinian prisoners being releasedThe Explainer Triumphant Donald Trump addresses the Israeli parliament as families on both sides of the Gaza war reunite with their loved ones
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Cytomegalovirus can cause permanent birth defectsThe Explainer The virus can show no symptoms in adults
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
